Professional Documents
Culture Documents
Patrick Chen, M.D. Department of Family Medicine San Francisco General Hospital March 3, 2006
Case Presentation
G.D. is a 48 yo male chef and restauranteur who presents to the UCSF Sports Medicine Clinic c/o 8-10 yrs of B knee pain. He is a devout outdoorsman whose active lifestyle is severely compromised by his knee pain.
Case Presentation
History: Site/Severity: Onset: Character:
Radiation:
Alleviation: Time:
Exacerbation:
Sx associated:
Case Presentation
History: Site/Severity: Onset: Character: medial knee L > R, 8/10 pain gradual, no acute trauma ache, joint soreness
Radiation:
Alleviation: Time:
none
rest, aspirin 8-10 yrs, lasts 10-15 min
Exacerbation:
Sx associated:
Case Presentation
History Continued..
Case Presentation
Physical Exam 57, 165 lbs, BMI 25.8 + mild medial joint line tenderness on L ROM of knees: L 0-130, R 0-140
Case Presentation
Case Presentation
Case Presentation
Case Presentation
Assessment s/p L meniscus injury B genu varus (bowlegged) B mild medial compartment OA, greater on L Management Use G2 unloader brace L knee w/ exercise 1st of 3 rounds of Synvisc injections B knee joints
Case Presentation
Follow-up: 1 week later Swelling L knee x 3 days after 1st injection 6/10 pain 2nd round of Synvisc injections B knees Follow-up: 2 weeks later Conducted exercise routine w/o swelling 2/10 pain 3rd round of Synvisc injections B knee RTC 6 months
Overview: Epidemiology
Knee OA most common cause of disability in adults
Overview: Definition
Arthritis vs. Arthrosis Gradual loss of articular cartilage in the knee joint 3 articulations:
1) Lateral condyles of the femur and tibia 2) Medial condyles of the femur and tibia 3) Patellofemoral joint
Damage caused by a complex interplay of joint integrity, biochemical processes, genetics, and mechanical forces
Clinical Approach to Knee Pain Differential Diagnosis Making The Diagnosis Management
Lifestyle Medical Surgical
History
SOCRATES pain questions Inflammatory sx e.g. fever, hot joint History of trauma or surgery Instability
Functional loss
Prior treatment
Vitals, BMI
Palpation: isolate tenderness, effusion, crepitus ROM: measure degree of flexion Stability: ligaments, menisci Alignment: genu varus or valgus Function: gait, duck waddle
MRI
Lateral Pain
OA LCL Meniscus Iliotibial band syndrome
Diffuse Pain
OA Infectious arthritis Gout, pseudogout RA
Anterior Pain
OA Patellofemoral syndrome Prepateller bursitis Quadriceps mechanism
Diagnosis of Knee OA
Classic Clinical Criteria
established by ACR, 1981 sensitivity 95%, specificity 69%
Diagnosis of Knee OA
Classification Tree Clinical symptoms Synovial fluid
1. 2. 3. WBC<2000/mm3 Clear color High Viscosity Osteophytes Loss of joint space Subchondral sclerosis Subchondral cysts
Sensitivity 94 %; Specificity 88 %
No OA
X-rays
1. 2. 3. 4.
Diagnosis of Knee OA
Management: Lifestyle
Weight loss
Nutrition referral
Exercise Program
PT referral Quadriceps strengthening ROM exercises Low impact activities e.g. swimming, biking 7
Management: Lifestyle
Varus (bowlegged) vs Valgus (knock-kneed)
G2 Unloader Brace
Management: Medical
Glucosamine/Chondroitin Acetaminophen NSAIDs Cox-2 inhibitors Opioids Intraarticular injections
Glucocorticoids Hyaluronans
Management: Medical
Glucosamine/Chondroitin
1500 mg/1200 mg daily ($40-50/month) Glucosamine: building block for glycosaminoglycans Chondroitin: glycosaminoglycan in articular cartilage GAIT study, NEJM, Feb 23, 2006
Multicenter, double blind, placebo-controlled, 24 wks, N=1583 Symptomatic mild or moderate-severe knee OA Infrequent mild side effects e.g. bloating For mild OA, not better than placebo For moderate-severe OA, combination showed benefit 8
Patient satisfaction
Management: Medical
Acetaminophen
Indication: mild-moderate pain 1000 mg Q6h PRN Better than placebo but less efficacious than NSAIDs 9 Caution in advanced hepatic disease
NSAIDs
Indication: moderate-severe pain, failed acetaminophen GI/renal/hepatic toxicity, fluid retention If risk of GIB, use anti-ulcer agents concurrently Agents have highly variable efficacy and toxicity
Management: Medical
NSAIDs
10
Management: Medical
Cox-2 inhibitors
Indication: mod-severe pain, failed NSAID, risk of GIB OA pain relief similar to NSAIDs Fewer GI events e.g. symptomatic ulcers, GIB Celecoxib 200 mg daily GI/renal toxicity, fluid retention Increased risk of CV events?
APC Trial: 700 pts each assigned to placebo, 200 BID, 400 BID Increased risk at higher doses 11 CLASS Trial: 8,000 pts compared Celecoxib vs Ibuprofen Similar risk to Ibuprofen 12
Management: Medical
Opioid Analgesics
Indication: Moderate-severe pain Acute exacerbations NSAIDs/Cox-2 inhibitors failed or contraindicated Oxycodone synergistic w/ NSAIDs 13 Tramadol/acetaminophen vs codeine/acetaminophen Similar pain relief 14 Avoid long-term use
Management: Medical
Intraarticular Injections Glucocorticoids
Indication: pain persists despite oral analgesics 40 mg/mL triamcinolone (kenalog-40)
Management: Medical
Intraarticular Injections Hyaluronans (e.g. Synvisc)
Indication: pain persists despite other agents Synthetic joint fluid Pain relief similar to steroid injections 2 mL injection Qwk x 3, $560-760/series Medicare reimburses 80%, Medi-cal $455.90 60-70% patients respond, relief up to 6 months Patient satisfaction 16, 17
Management: Medical
Intraarticular Injections Technique
22 gauge 1.5 inch needle Approach accuracy:
Lateral mid-patellar 93% 18
Patient supine Leg straight Manipulate patella Angle needle slightly posteriorly Inject after drop in resistance or fluid aspirated
Management: Algorithm
Lifestyle Modifications Acetaminophen PRN
NSAIDs PRN
Celecoxib
Steroid Injections
Opioids PRN
Hyaluronan Injections
Surgical Referral
Management: Surgical
When to Refer
Knee pain or functional status has failed to improve with non-operative management
Types of Procedures
Arthroscopic Irrigation Arthroscopic Debridement High Tibial Osteotomy Partial Knee Arthroplasty Total Knee Arthroplasty
Management: Surgical
High Tibial Osteotomy
Indication:
Unicompartmental arthritis Genu varus or valgus Realign mechanical axis Age < 60yo < 15 degrees deformity19
Management: Surgical
Partial Knee Arthroplasty
Indication: Unicompartmental arthritis Ligaments spared Increased ROM Faster recovery Prosthesis 10-yr survival: 84% 20
Management: Surgical
Total Knee Arthroplasty
Indication:
Diffuse arthritis Severe pain Functional impairment
Pain relief > functional gain ACL sacrificed PCL also may be sacrificed Prosthesis 10-yr survival: 90% 21
Clinical Pearls
Assess functional loss
Bibliography
1. Lawrence RC, Helmick CG, Arnett FC, et al. Estimates of The Prevalence of Arthritis And Selected Musculoskeletal Disorders in The United States. Arthritis And Rheumatism 1998;43:778-799. 2. Felson DT, Zhang Y. An Update on The Epidemiology of Knee And Hip Osteoarthritis with A View to Prevention. Arthritis And Rheumatism 1998;41:1343-55. 3. Brandt, K. Osteoarthritis: Clinical Patterns And Pathology. In: Textbook of Rheumatology, 5th edition. Kelley WN, Harris Jr ED, Ruddy S, Sledge CE (Eds), W.B. Saunders, Philadelphia, 1997, p.1383. 4. Buckwalter JA. Osteoarthritis And Articular Cartilage Use, Disuse, And Abuse: Experimental Studies. Journal of Rheumatological Suppl 1995; 43:13. 5. Altman R, Asch E, Bloch D, et al. Development of Criteria for The Classification And Reporting of Osteoarthritis, Classification of Osteoarthritis of The Knee. Arthritis And Rheumatism 1986; 29:1039. 6. Klashman D, Seeger L, Singh R, et al. Validation of Nonradiographic ACR Osteoarthritis Criteria Using ACR Arthroscopy Damage Index as Comparison Standard. Arthritis And Rheumatism 1996; 39:172. 7. Thomas KS, Muir KR, Doherty M, Jones AC, OReilly SC, Bassey EJ. Home Based Exercise Programme for Knee Pain And Knee Osteoarthritis: Randomised Controlled Trial. British Medical Journal 2002. Oct 5; 325(7367):752. 8. Clegg DO, Reda DJ, Harris CL, et al. Gluosamine, Chondroitin Sulfate, and the Two in Combination for Painful Knee Arthritis. NEJM 2006, Volume 354 No. 8:795-808. 9. Zhang W, Jones A, Doherty M. Does Paracetamol (Acetaminophen) Reduce The Pain of Osteoarthritis? A Meta-analysis of Randomised Controlled Trials. Annals of The Rheumatic Diseases 2004; 63:901. 10. Kalunian KC, Concoff AL, Brion PH. Pharmacologic and Surgical Therapy of Osteoarthritis in UpToDate 2006 [online journal]. Vol 13.2, March, 2005. 11. Solomon SD, McMurray JJ, Pfeffer MA, et al. Cardiovascular risk associated with celecoxib in a clinical trial for colorectal adenoma prevention. NEJM 2005; 352:1071.
Bibliography
12. Silverstein FE, Faich G, Goldstein JL, et al. Gastrointestinal Toxicity with Celecoxib Vs. Nonsteroidal Anti-inflammatory Drugs for Osteoarthritis And Rheumatoid Arthritis. The CLASS Study: A Randomized Controlled Trial. JAMA 2000; 284:1247. 13. Caldwell JR, Hale ME, Boyd RE, et al. Treatment of Osteoarthritis Pain with Controlled Release Oxycodone or Fixed Combination Oxycodone Plus Acetaminophen Added to Nonsteroidal Antiinflammatory Drugs: A Double Blind, Randomized, Multicenter, Placebo Controlled Trial. Journal of Rheumatology 1999; 26:862. 14. Mullican WS, Lacy JR. Tramadol/Acetaminophen Combination Tablets And Codeine/Acetaminophen Combination Capsules for The Management of Chronic Pain: A Comparative Trial. Clinical Therapeutics 2001; 23:1429. 15. Arroll B, Goodyear-Smith F. Corticosteroid Injections for Osteoarthritis of The Knee: Metaanalysis. British Medical Journal 2004; 328:869. 16. Moreland LW, Arnold WJ, Saway A, et al. Efficacy And Safety of Intra-articular Hylan G-F 20 (Synvisc), A Viscoelastic Derivative of Hyaluronan in Patients with Osteoarthritis of The Knee. Arthritis Rheum 1993; 36:S165. 17. Lo GH, LaValley M, McAlindon T, Felson DT. Intra-articular Hyaluronic Acid in Treatment of Knee Osteoarthritis: Meta-analysis. JAMA 2003; 290:3115. 18. Jackson DW, Evans NA, Thoomas BM, Accuracy of Needle Placement Into The Intraarticular Space of The Knee. The Journal of Bone and Joint Surgery (American) 2002; 84:15221527. 19. Kalunian KC, Concoff AL, Brion PH. Pharmacologic And Surgical Therapy of Osteoarthritis in UpToDate 2006 [online journal]. Vol 13.2, March, 2005. 20. Ibid. 21. Ibid.